Advancing Early Lung Cancer Detection Symposium

PUBLISHED ON May 15, 2019

bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods necessary to find lung cancer at its earliest stages.

read more

bioAffinity Technologies is proud to play a part in the University of Texas Health video highlighting our impressive research collaboration to uncover the mechanisms of cancer. The collaboration with the University of Texas, a leader in innovation, has led to exciting advancements that further the development and commercialization of our life-saving tests and treatments for cancer. In this video, you’ll see physicians, scientists, and bioAffinity Technologies CEO Maria Zannes discuss how medical breakthroughs are being commercialized and made available to those who need them, including more about how we’re moving forward with our CyPath® diagnostic tests and OncoSelect® therapeutics.